Back
Delta Air Lines Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
53
DAL
Delta Air Lines
Last Price:
$47.20
Seasonality Move:
6%
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
$17.70
Seasonality Move:
-9.52%
Buy
53
Delta Air Lines (DAL)
is a Buy
Is Delta Air Lines a Buy, Sell or Hold?
-
The current Delta Air Lines [DAL] share price is $47.20. The Score for DAL is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
DAL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $17.69. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAL Stock Price Chart
What is Delta Air Lines's stock price today?
-
The Delta Air Lines share price today is $47.20The current trend is moderately bearish and DAL is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $17.69Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
DAL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 45.76 | Sell |
Chaikin Money Flow: | -9181761 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (47.8 - 50.4) | Sell |
Bollinger Bands (100): | (41.8 - 60.16) | Sell |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 42.98 | Sell |
Chaikin Money Flow: | -561522 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17.2 - 19.06) | Sell |
Bollinger Bands (100): | (17.72 - 26.54) | Sell |
DAL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.54 | Sell |
20-day SMA: | 48.85 | Sell |
50-day SMA: | 46.36 | Buy |
200-day SMA: | 53.83 | Sell |
8-day EMA: | 48.21 | Sell |
20-day EMA: | 48.42 | Sell |
50-day EMA: | 43.8 | Buy |
200-day EMA: | 21.84 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.56 | Sell |
20-day SMA: | 18.3 | Sell |
50-day SMA: | 18.27 | Sell |
200-day SMA: | 26.83 | Sell |
8-day EMA: | 18.25 | Sell |
20-day EMA: | 18.36 | Sell |
50-day EMA: | 19.23 | Sell |
200-day EMA: | 26.97 | Sell |
Delta Air Lines Earnings Growth & DAL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $1.10 per share, a decrease this year of $0.63 per share, and an increase next year of $1.31 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.
Delta Air Lines Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |